CLAD samples included both predominant phenotypes of RAS and BOS; no significant difference was noted in eIF4E (Ser209) phosphorylation between RAS and BOS MCs (P = 0.59). The gene discussed is EIF4E; the disease is Buschke-Ollendorff syndrome.